Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 614.00
Bid: 612.00
Ask: 622.00
Change: 6.00 (0.99%)
Spread: 10.00 (1.634%)
Open: 610.00
High: 622.00
Low: 610.00
Prev. Close: 608.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update & appointment of an Independent NED

21 Sep 2016 07:00

RNS Number : 3721K
Porvair PLC
21 September 2016
 

For immediate release 21 September 2016

 

 

Porvair plc

 

Nine months trading update and appointment of an Independent Non-Executive Director

 

Porvair plc ("Porvair"), the specialist filtration and environmental technology group, today issues the following trading update for the nine months ended 31 August 2016.

Porvair continues to trade well. Revenues at constant currency for the nine months ended 31 August 2016 were 8% higher than in the nine months to 31 August 2015. Profit before tax was ahead of the prior year and in line with management's expectations.

The Microfiltration division was the main contributor to growth. Aerospace revenues are at record levels and the US acquisition, TEM, made earlier in the year has traded well. Metals Filtration has returned to growth in the third quarter of the year after a slower start and production in the new facility in China is going well.

The significant weakening of Sterling in the third quarter will improve the Group's full year reported revenue growth but, as a result of forward currency sales contracted early in the financial year, is expected to have little impact on full year earnings in 2016.

At 31 August 2016, the Group had net cash of £6m (31 August 2015: £9m) with the £2.9m paid for the acquisition of TEM largely accounting for the difference. Order books for the final quarter are healthy.

The Board is pleased to announce the appointment of Sally Martin as an Independent Non-Executive Director with effect from 1 October 2016. Sally will join the Audit Committee, Remuneration Committee and Nominations Committee of Porvair.

Sally Martin is Vice President for Health, Safety, Security and Environmental in the Downstream division of Shell International Petroleum. In a thirty-year career with Shell, Sally has built a strong track record in strategy; M&A; international business development; and engineering and operations. She is a member of the Chartered Institute of Electrical Engineers.

Porvair confirms that there are no further matters to be disclosed pursuant to the requirements of paragraph 9.6.13 of the Listing Rules of the UK Listing Authority.

 

 

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

 

Chris Tyler, Group Finance Director

 

 

 

Buchanan Communications

0207 466 5000

Charles Ryland / Stephanie Watson

 

 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. Its principal markets are aviation, energy and industrial process, environmental laboratories and non-ferrous metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCURVVRNKAKUAR
Date   Source Headline
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.